贵阳朗玛信息技术股份有限公司 2017 年第一季度报告全文 贵阳朗玛信息技术股份有限公司 2017 年第一季度报告（修正后） 2018 年 04 月 1 / 26 贵阳朗玛信息技术股份有限公司 2017 年第一季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人王伟、主管会计工作负责人王春及会计机构负责人(会计主管人 员)马勇声明：保证季度报告中财务报表的真实、准确、完整。 2 / 26 贵阳朗玛信息技术股份有限公司 2017 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否因会计政策变更及会计差错更正等追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期 | | --- | --- | --- | --- | | | | | 增减 | | 营业总收入（元） | 98,412,442.24 | 90,069,170.41 | 9.26% | | ...

贵阳朗玛信息技术股份有限公司 2017 年第三季度报告全文 贵阳朗玛信息技术股份有限公司 2017 年第三季度报告 2017 年 10 月 1 贵阳朗玛信息技术股份有限公司 2017 年第三季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人王伟、主管会计工作负责人王春及会计机构负责人(会计主管人 员)马勇声明：保证季度报告中财务报表的真实、准确、完整。 2 贵阳朗玛信息技术股份有限公司 2017 年第三季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末 | | --- | --- | --- | --- | --- | | | | | | 增减 | | 总资产（元） | 3,483,752,818.96 | | 1,369,860,816.34 | 154.31% | | 归属于上市公司股 ...

2017 年 08 月 1 贵阳朗玛信息技术股份有限公司 2017 年半年度报告全文 贵阳朗玛信息技术股份有限公司 2017 年半年度报告全文 贵阳朗玛信息技术股份有限公司 2017 年半年度报告 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的 真实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别 和连带的法律责任。 公司负责人王伟、主管会计工作负责人余周军及会计机构负责人(会计主管 人员)马勇声明：保证本半年度报告中财务报告的真实、准确、完整。 除下列董事外，其他董事亲自出席了审议本次半年报的董事会会议 | 未亲自出席董事姓名 | 未亲自出席董事职务 | 未亲自出席会议原因 | 被委托人姓名 | | --- | --- | --- | --- | | 靳国文 | 董事 | 出差 | 黄国宏 | 本报告中如有涉及未来的计划、业绩预测等方面的内容，均不构成本公司 对任何投资者及相关人士的承诺。投资者及相关人士均应对此保持足够的风险 认识，并且应当理解计划、预测与承诺之间的差异。公司在本报告第四节"经营 情况讨论与分析"之"十、公司面临的风险和应对措 ...

贵阳朗玛信息技术股份有限公司 2016 年年度报告全文 贵阳朗玛信息技术股份有限公司 2016 年年度报告 2017 年 03 月 1 贵阳朗玛信息技术股份有限公司 2016 年年度报告全文 第一节 重要提示、目录和释义 本公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的 真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和 连带的法律责任。 公司负责人王伟、主管会计工作负责人余周军及会计机构负责人(会计主管 人员)马勇声明：保证年度报告中财务报告的真实、准确、完整。 除下列董事外，其他董事亲自出席了审议本次年报的董事会会议 | 未亲自出席董事姓名 | 未亲自出席董事职务 | 未亲自出席会议原因 | 被委托人姓名 | | --- | --- | --- | --- | | 靳国文 | 董事 | 出差 | 黄国宏 | 本报告中如有涉及未来的计划、业绩预测等方面的内容，均不构成本公司 对任何投资者及相关人士的承诺。投资者及相关人士均应对此保持足够的风险 认识，并且应当理解计划、预测与承诺之间的差异。公司在本报告第四节"管理 层分析与讨论"之"九、公司未来发展的展望"部分，详细描述了公 ...

贵阳朗玛信息技术股份有限公司 2017 年第一季度报告全文 贵阳朗玛信息技术股份有限公司 2017 年第一季度报告 2017 年 04 月 1 / 29 贵阳朗玛信息技术股份有限公司 2017 年第一季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人王伟、主管会计工作负责人余周军及会计机构负责人(会计主管 人员)马勇声明：保证季度报告中财务报表的真实、准确、完整。 2 / 29 贵阳朗玛信息技术股份有限公司 2017 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否因会计政策变更及会计差错更正等追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期 | | --- | --- | --- | --- | | | | | 增减 | | 营业总收入（元） | 280,134,177.25 | 90,069,170.41 | 211.02% | | ...

贵阳朗玛信息技术股份有限公司 2016 年年度报告全文 贵阳朗玛信息技术股份有限公司 2016 年年度报告 2017 年 03 月 中国整体宏观环境的变化、社会老龄化的到来，医疗健康服务业将成为未 来国民经济的亮点。国家医疗卫生体制改革进一步深化，"互联网+医疗"战略的 提出，更使得互联网医疗成为投资界的"风口"。诸多资金的涌入，特别是医药 行业大公司涉足互联网、BAT 等互联网巨头在医疗健康领域的布局，使得互联 网医疗行业的竞争日益加剧。另一方面，自公司 2014 年转向互联网医疗方向以 来，相继收购了启生信息、控股六医公司，参与投资设立了医药电商和叁玖互 2 第一节 重要提示、目录和释义 本公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的 真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和 连带的法律责任。 公司负责人王伟、主管会计工作负责人余周军及会计机构负责人(会计主管 人员)马勇声明：保证年度报告中财务报告的真实、准确、完整。 除下列董事外，其他董事亲自出席了审议本次年报的董事会会议 | 未亲自出席董事姓名 | 未亲自出席董事职务 | 未亲自出席会议原因 | 被委托人 ...

贵阳朗玛信息技术股份有限公司 2016 年第三季度报告全文 贵阳朗玛信息技术股份有限公司 2016 年第三季度报告 2016 年 10 月 1 / 38 贵阳朗玛信息技术股份有限公司 2016 年第三季度报告全文 第一节 重要提示 本公司董事会、监事会及其董事、监事、高级管理人员保证本报告所载资 料不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准 确性和完整性承担个别及连带责任。 公司负责人王伟、主管会计工作负责人余周军及会计机构负责人(会计主管 人员)马勇声明：保证季度报告中财务报告的真实、完整。 2 / 38 除下列董事外，其他董事亲自出席了审议本次季报的董事会会议 未亲自出席董事姓名 未亲自出席董事职务 未亲自出席会议原因 被委托人姓名 靳国文 董事 出差 刘玲 王欣 独立董事 出差 张克 赵志军 独立董事 出差 张克 贵阳朗玛信息技术股份有限公司 2016 年第三季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否因会计政策变更及会计差错更正等追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末 | | - ...

[Important Notes and Definitions](index=2&type=section&id=%E7%AC%AC%E4%B8%80%E8%8A%82%20%E9%87%8D%E8%A6%81%E6%8F%90%E7%A4%BA%E3%80%81%E9%87%8A%E4%B9%89) [Important Notes](index=2&type=section&id=%E9%87%8D%E8%A6%81%E6%8F%90%E7%A4%BA) The board guarantees the report's authenticity and plans no dividend distribution for this period - The company's Board of Directors, Supervisory Committee, and senior management guarantee the truthfulness, accuracy, and completeness of the report's contents[3](index=3&type=chunk) - The company **does not plan to distribute cash dividends**, issue bonus shares, or convert capital reserves into share capital[5](index=5&type=chunk) - Two directors, Jin Guowen and Wang Xin, were unable to attend the board meeting in person due to business travel and appointed proxies to attend on their behalf[6](index=6&type=chunk) [Definitions](index=4&type=section&id=%E9%87%8A%E4%B9%89) This section provides definitions for frequently used terms, including company names, key products, subsidiaries, and the reporting period - Defines "the Company/Listed Company/Longmaster Information" as Guiyang Longmaster Information & Technology Co, Ltd[9](index=9&type=chunk) - Explains "Phone Duipeng" as a large-scale voice social entertainment platform operated by Longmaster Information[9](index=9&type=chunk) - Lists multiple subsidiaries and affiliated companies, such as Qisheng Information, Guiyang Sixth People's Hospital, Guiyang Internet Hospital Management Company, Pharmaceutical E-commerce, and 39 Internet Hospital[9](index=9&type=chunk) [Company Profile](index=5&type=section&id=%E7%AC%AC%E4%BA%8C%E8%8A%82%20%E5%85%AC%E5%8F%B8%E5%9F%BA%E6%9C%AC%E6%83%85%E5%86%B5%E7%AE%80%E4%BB%8B) [Company Information](index=5&type=section&id=%E4%B8%80%E3%80%81%E5%85%AC%E5%8F%B8%E4%BF%A1%E6%81%AF) This section provides the company's basic registration information, including stock ticker, name, legal representative, and contact details - Stock Ticker: Longmaster Information, Stock Code: 300288[11](index=11&type=chunk) - The company's legal representative is Wang Wei, and the registered address is Room 130, Chuangye Building, Jinyang Science and Technology Industrial Park, Guiyang High-tech Zone[11](index=11&type=chunk) [Contact Persons and Methods](index=5&type=section&id=%E4%BA%8C%E3%80%81%E8%81%94%E7%B3%BB%E4%BA%BA%E5%92%8C%E8%81%94%E7%B3%BB%E6%96%B9%E5%BC%8F) This section lists the contact information for the Board Secretary, Yu Zhoujun, and the Securities Affairs Representative, Wang Chun - The Board Secretary is Yu Zhoujun, and the Securities Affairs Representative is Wang Chun[12](index=12&type=chunk) - The contact address is 2nd Floor, National Digital Content Industrial Park, No 31 Changling South Road, Guanshanhu District, Guiyang, with the phone number 0851-83842119[12](index=12&type=chunk) [Information Disclosure and Report Availability](index=5&type=section&id=%E4%B8%89%E3%80%81%E4%BF%A1%E6%81%AF%E6%8A%AB%E9%9C%B2%E5%8F%8A%E5%A4%87%E7%BD%AE%E5%9C%B0%E7%82%B9) This section specifies the designated media for information disclosure and the location where the report is available for inspection - The designated newspapers for information disclosure are China Securities Journal, Securities Times, and Shanghai Securities News[13](index=13&type=chunk) - The designated website is cninfo.com.cn, and the report is available at the company's securities department[13](index=13&type=chunk) [Key Accounting Data and Financial Indicators](index=6&type=section&id=%E5%9B%9B%E3%80%81%E4%B8%BB%E8%A6%81%E4%BC%9A%E8%AE%A1%E6%95%B0%E6%8D%AE%E5%92%8C%E8%B4%A2%E5%8A%A1%E6%8C%87%E6%A0%87) The company's revenue and net profit grew, while operating cash flow slightly decreased Key Accounting Data and Financial Indicators (YoY Change) | Indicator | Current Period (Yuan) | Prior Year Period (Yuan) | YoY Change | | :--- | :--- | :--- | :--- | | Total Operating Revenue | 189,515,427.50 | 157,451,004.08 | 20.36% | | Net Profit Attributable to Shareholders of the Listed Company | 39,133,898.86 | 34,903,170.71 | 12.12% | | Net Profit Attributable to Shareholders of the Listed Company after Non-recurring Items | 30,559,388.58 | 27,585,581.99 | 10.78% | | Net Cash Flow from Operating Activities | 35,021,643.62 | 35,103,514.10 | -0.23% | | Basic Earnings Per Share (Yuan/Share) | 0.12 | 0.10 | 20.00% | | Diluted Earnings Per Share (Yuan/Share) | 0.12 | 0.10 | 20.00% | | Weighted Average Return on Equity | 3.91% | 3.89% | 0.02% | | Weighted Average Return on Equity after Non-recurring Items | 3.06% | 3.07% | -0.01% | | **End of Current Period (Yuan)** | **End of Prior Year (Yuan)** | **Change from Prior Year-End** | | | Total Assets | 1,279,181,337.75 | 1,206,757,190.57 | 6.00% | | Equity Attributable to Shareholders of the Listed Company | 1,019,425,918.64 | 980,292,019.78 | 3.99% | | Net Assets Per Share Attributable to Shareholders of the Listed Company (Yuan/Share) | 3.0166 | 2.9008 | 3.99% | [Non-recurring Gains and Losses](index=6&type=section&id=%E4%BA%94%E3%80%81%E9%9D%9E%E7%BB%8F%E5%B8%B8%E6%80%A7%E6%8D%9F%E7%9B%8A%E9%A1%B9%E7%9B%AE%E5%8F%8A%E9%87%91%E9%A2%9D) Non-recurring gains and losses totaled 8.57 million yuan, mainly from government subsidies and debt restructuring gains Non-recurring Items and Amounts | Item | Amount (Yuan) | Notes | | :--- | :--- | :--- | | Gain/Loss on Disposal of Non-current Assets | -1,100.25 | | | Government Subsidies Included in Current Profit or Loss | 7,673,664.22 | Government subsidies received in prior years recognized in the current period amounted to 7,182,554.22 yuan, and subsidies received and recognized in the current period amounted to 491,110.00 yuan | | Gain/Loss on Debt Restructuring | 3,491,621.35 | Debt forgiveness from suppliers to Sixth People's Hospital | | Fair Value Changes in Financial Assets/Liabilities and Investment Income from Disposal | 123,716.60 | Income from subsidiary's wealth management products | | Other Non-operating Income and Expenses | -676.01 | | | Less: Income Tax Effect | 1,516,788.03 | | | Minority Interest Effect (After Tax) | 1,195,927.60 | Including: 1,185,010.09 yuan for minority shareholders of Sixth People's Hospital and 10,917.51 yuan for minority shareholders of Mengcheng Interactive | | **Total** | **8,574,510.28** | | [Differences under Domestic and Foreign Accounting Standards](index=7&type=section&id=%E5%85%AD%E3%80%81%E5%A2%83%E5%86%85%E5%A4%96%E4%BC%9A%E8%AE%A1%E5%87%86%E5%88%99%E4%B8%8B%E4%BC%9A%E8%AE%A1%E6%95%B0%E6%8D%AE%E5%B7%AE%E5%BC%82) No discrepancies exist between financial reports prepared under Chinese accounting standards and international or foreign standards - No differences in net profit or net assets were reported between financial statements prepared under international accounting standards and Chinese accounting standards[18](index=18&type=chunk) - No differences in net profit or net assets were reported between financial statements prepared under foreign accounting standards and Chinese accounting standards[19](index=19&type=chunk)[20](index=20&type=chunk) [Major Risk Warning](index=8&type=section&id=%E4%B8%83%E3%80%81%E9%87%8D%E5%A4%A7%E9%A3%8E%E9%99%A9%E6%8F%90%E7%A4%BA) The company faces challenges from market competition, regulatory changes, talent attrition, and internal management risks - **Intensified market competition risk**: The internet healthcare industry attracts significant capital and major players, requiring the company to maintain its competitive edge in R&D, technology, and business models[21](index=21&type=chunk) - **Risk of regulatory changes**: The healthcare industry is heavily influenced by policies, payment systems, and industry structures, posing challenges to the development of internet healthcare[21](index=21&type=chunk) - **Risk of losing key technical personnel and medical experts**: The company's reliance on its core technical and expert teams means that talent attrition could weaken its competitive advantage[22](index=22&type=chunk) - **Internal management risk**: The company's expansion into internet healthcare has increased its asset and business scale, demanding higher standards for operational management and internal controls[22](index=22&type=chunk)[23](index=23&type=chunk) [Board of Directors' Report](index=10&type=section&id=%E7%AC%AC%E4%B8%89%E8%8A%82%20%E8%91%A3%E4%BA%8B%E4%BC%9A%E6%8A%A5%E5%91%8A) [Financial Condition and Operating Results](index=10&type=section&id=%E4%B8%80%E3%80%81%E6%8A%A5%E5%91%8A%E6%9C%9F%E5%86%85%E8%B4%A2%E5%8A%A1%E7%8A%B6%E5%86%B5%E5%92%8C%E7%BB%8F%E8%90%A5%E6%88%90%E6%9E%9C) The company advanced its "Internet + Healthcare" strategy, achieving rapid growth in its internet hospital business and steady overall operations [Overall Operating Performance](index=10&type=section&id=1%E3%80%81%E6%8A%A5%E5%91%8A%E6%9C%9F%E5%86%85%E6%80%BB%E4%BD%93%E7%BB%8F%E8%90%A5%E6%83%85%E5%86%B5) The internet hospital business expanded rapidly, while traditional and new communication services provided stable revenue and growth - Guizhou Internet Hospital has deployed 100 consultation points with an average of **over 1,500 daily video consultations**, targeting 3,000-5,000 daily consultations by year-end 2016[26](index=26&type=chunk) - 39 Internet Hospital covers approximately 200 primary care institutions and 300 high-level medical experts, completing over 80 complex case consultations[27](index=27&type=chunk) - The subsidiary, Sixth People's Hospital, generated **46.19 million yuan in medical service revenue** during the reporting period[27](index=27&type=chunk) - 39 Health Net generated **74.28 million yuan in internet medical information service revenue** and enhanced its content and new media presence[28](index=28&type=chunk) - The affiliated company, Pharmaceutical E-commerce, plans to acquire a 70.4% stake in Guizhou Kangxin Pharmaceutical Co, Ltd to enhance profitability[29](index=29&type=chunk) - The company invested in Sichuan Laya Micro-technology Co, Ltd to enter the wearable medical device market, strengthening its internet healthcare ecosystem[29](index=29&type=chunk) - The "Phone Duipeng" business generated **55.05 million yuan in revenue**, while the mobile resale business contributed **13.62 million yuan**, becoming a new growth driver[30](index=30&type=chunk)[31](index=31&type=chunk) Year-over-Year Changes in Key Financial Data | Indicator | Current Period (Yuan) | Prior Year Period (Yuan) | YoY Change | Reason for Change | | :--- | :--- | :--- | :--- | :--- | | Operating Revenue | 189,515,427.50 | 157,451,004.08 | 20.36% | | | Operating Costs | 76,182,990.61 | 45,665,206.85 | 66.83% | Due to the consolidation of 44,801,658.23 yuan in operating costs from Sixth People's Hospital | | Selling Expenses | 17,180,977.30 | 21,132,632.05 | -18.70% | | | Administrative Expenses | 64,392,641.43 | 53,918,958.41 | 19.42% | | | Finance Expenses | -2,778,013.98 | -2,883,797.54 | 3.67% | | | Income Tax Expense | 8,482,428.63 | 11,158,858.22 | -23.98% | | | R&D Investment | 15,803,213.75 | 15,439,940.22 | 2.35% | | | Net Cash Flow from Operating Activities | 35,021,643.62 | 35,103,514.10 | -0.23% | | | Net Cash Flow from Investing Activities | -110,662,791.54 | -103,763,515.40 | -6.65% | | | Net Cash Flow from Financing Activities | -30,086,000.00 | 29,648,705.74 | -201.47% | Due to the termination of a private placement project and the refund of a 30 million yuan subscription payment from Wu Zhenfa | | Net Increase in Cash and Cash Equivalents | -105,727,147.92 | -39,011,295.56 | -171.02% | Due to increased cash outflows from investing and financing activities | | Asset Impairment Loss | 205,099.78 | 2,284,097.58 | -91.02% | Due to the impairment provision for the equity investment in Guiyang Wangyang Digital Entertainment in the prior period | | Investment Income | 758,351.96 | 5,088,256.94 | -85.10% | Due to the investment income from the sale of a 10% stake in Guiyang Dongshiyun Technology in the prior period | | Non-operating Income | 11,195,084.16 | 3,534,297.46 | 216.76% | Due to the recognition of government subsidies and the consolidation of 3,493,789.80 yuan in debt restructuring gains from Sixth People's Hospital | | Non-operating Expenses | 31,574.85 | 111,232.65 | -71.61% | Due to a decrease in settlement compensation from Qisheng Information | | Notes Receivable | 600,000.00 | 100,000.00 | 500.00% | Due to an increase in bank acceptance bills received by Qisheng Information | | Accounts Receivable | 75,749,297.05 | 57,044,068.99 | 32.79% | Due to the consolidation of 24,458,557.97 yuan in accounts receivable from Sixth People's Hospital | | Interest Receivable | 2,428,057.86 | 1,385,241.68 | 75.28% | Due to accrued interest on term deposits by Qisheng Information | | Other Receivables | 13,105,179.38 | 6,856,585.36 | 91.13% | Due to a 5,007,900.36 yuan receivable from Guiyang High-tech Holding Group for advanced tax payments | | Inventory | 6,875,424.61 | 423,253.83 | 1,524.42% | Due to the consolidation of 6,398,476.22 yuan in inventory from Sixth People's Hospital | | Other Current Assets | 42,535,600.65 | 21,069,023.67 | 101.89% | Due to an increase in wealth management products purchased by Qisheng Information | | Long-term Equity Investments | 51,818,499.49 | 19,693,864.13 | 163.12% | Due to investments of 19.5 million yuan in Guiyang Pharmaceutical E-commerce, 10 million yuan in Sichuan Laya, and 1.99 million yuan in Guiyang 39 Internet Hospital | | Fixed Assets | 116,172,307.01 | 10,580,088.08 | 998.03% | Due to the reclassification of the Longmaster office building from construction in progress and the consolidation of 48,304,493.95 yuan in fixed assets from Sixth People's Hospital | | Construction in Progress | 0.00 | 64,555,495.84 | -100.00% | Due to the reclassification of the Longmaster office building to fixed assets | | Intangible Assets | 83,319,896.29 | 31,655,274.76 | 163.21% | Due to the consolidation of 55,464,763.12 yuan in intangible assets from Sixth People's Hospital | | Long-term Deferred Expenses | 368,334.79 | 271,734.80 | 35.55% | Due to office renovation costs for Guiyang Internet Hospital Management Company | | Accounts Payable | 33,569,528.26 | 8,849,205.11 | 279.35% | Due to the consolidation of 22,184,011.13 yuan in accounts payable from Sixth People's Hospital | | Advances from Customers | 21,750,356.32 | 11,804,451.73 | 84.26% | Due to an increase in prepaid phone bills from the mobile resale business | | Employee Benefits Payable | 18,015,740.44 | 12,706,724.70 | 41.78% | Due to the consolidation of 7,966,869.71 yuan in employee compensation from Sixth People's Hospital | | Non-current Liabilities Due within One Year | 0.00 | 63,447,840.40 | -100.00% | Due to the payment for the acquisition of Qisheng Information | | Other Current Liabilities | 7,516,986.90 | 4,499,541.12 | 67.06% | Due to an increase in government subsidies to be recognized in the second half of the year | | Minority Interests | 69,891,218.54 | 5,949,199.51 | 1,074.80% | Due to the consolidation of Sixth People's Hospital, recognizing 66,700,625.10 yuan in minority interests | [Specific Factors Driving Revenue Changes](index=15&type=section&id=2%E3%80%81%E6%8A%A5%E5%91%8A%E6%9C%9F%E5%86%85%E9%A9%B1%E5%8A%A8%E4%B8%9A%E5%8A%A1%E6%94%B6%E5%85%A5%E5%8F%98%E5%8C%96%E7%9A%84%E5%85%B7%E4%BD%93%E5%9B%A0%E7%B4%A0) Revenue growth was driven by new mobile resale services and the consolidation of medical service income - Revenue from the 39 Health Net medical information service, operated by Qisheng Information, grew steadily, reaching **74.28 million yuan**[36](index=36&type=chunk) - The consolidation of Sixth People's Hospital contributed **46.19 million yuan** in medical service revenue[36](index=36&type=chunk) - Revenue from the "Phone Duipeng" business remained stable at **55.05 million yuan**[36](index=36&type=chunk) - The mobile resale business grew rapidly, generating **13.62 million yuan** in revenue and becoming a new performance driver[36](index=36&type=chunk) - Driven by these factors, the company's total operating revenue **increased by 20.36%** year-over-year[36](index=36&type=chunk) [Main Business Operations](index=15&type=section&id=3%E3%80%81%E4%B8%BB%E8%90%A5%E4%B8%9A%E5%8A%A1%E7%BB%8F%E8%90%A5%E6%83%85%E5%86%B5) The company's revenue is primarily derived from medical information, telecom value-added, mobile resale, and hospital services - The company's main revenue sources are internet medical information services, telecom value-added services ("Phone Duipeng"), mobile resale, and hospital medical services[37](index=37&type=chunk) - Qisheng Information's 39 Health Net generated **74.28 million yuan** in internet medical information service revenue[37](index=37&type=chunk) - The "Phone Duipeng" business generated **55.05 million yuan** in revenue, with its decline slowing and stabilizing[37](index=37&type=chunk)[38](index=38&type=chunk) - The mobile resale business generated **13.62 million yuan** in revenue, becoming a new growth driver[38](index=38&type=chunk) - Sixth People's Hospital, now consolidated, contributed **46.19 million yuan** in medical service revenue[38](index=38&type=chunk) Main Business Composition (by Product or Service) | Product or Service | Operating Revenue (Yuan) | Operating Cost (Yuan) | Gross Margin | Revenue YoY Change | Cost YoY Change | Gross Margin YoY Change | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | Phone Duipeng & Pengpeng Coin | 55,050,091.60 | 5,150,463.50 | 90.64% | -0.31% | -27.75% | 3.55% | | Mobile Resale | 13,622,539.40 | 12,366,477.18 | 9.22% | | | | | Medical Information Services | 74,275,765.47 | 13,846,628.77 | 81.36% | 3.63% | -6.88% | 2.11% | | Medical Services | 46,188,084.47 | 44,801,658.23 | 3.00% | | | | | Other | 378,946.56 | 17,762.93 | 95.31% | -85.09% | -96.70% | 16.51% | | **Total** | **189,515,427.50** | **76,182,990.61** | **59.80%** | **20.36%** | **66.83%** | **-11.20%** | [Other Main Business Activities](index=17&type=section&id=4%E3%80%81%E5%85%B6%E4%BB%96%E4%B8%BB%E8%90%A5%E4%B8%9A%E5%8A%A1%E6%83%85%E5%86%B5) The profit and business structure changed significantly due to the addition of mobile resale and medical services - The profit composition changed this period with the addition of the parent company's mobile resale business and the consolidation of profits and losses from the subsidiary, Guiyang Sixth People's Hospital[41](index=41&type=chunk) - The main business composition was altered by the addition of the parent company's mobile resale business and medical services from the subsidiary, Guiyang Sixth People's Hospital[42](index=42&type=chunk) - The overall gross margin **decreased by 11.20%** year-over-year, primarily due to the lower margins of the newly added mobile resale and medical service businesses[43](index=43&type=chunk) - The company's main products this period included Phone Duipeng, mobile resale, medical information services, medical services, and gaming[44](index=44&type=chunk) [Changes in Top 5 Suppliers or Customers](index=17&type=section&id=5%E3%80%81%E5%85%AC%E5%8F%B8%E5%89%8D%205%20%E5%A4%A7%E4%BE%9B%E5%BA%94%E5%95%86%E6%88%96%E5%AE%A2%E6%88%B7%E7%9A%84%E5%8F%98%E5%8C%96%E6%83%85%E5%86%B5) No significant changes occurred in the company's top 5 suppliers or customers during the reporting period - Changes in the top 5 suppliers and their impact: Not applicable[45](index=45&type=chunk) - Changes in the top 5 customers and their impact: Not applicable[45](index=45&type=chunk) [Analysis of Major Investee Companies](index=18&type=section&id=6%E3%80%81%E4%B8%BB%E8%A6%81%E5%8F%82%E8%82%A1%E5%85%AC%E5%8F%B8%E5%88%86%E6%9E%90) The major investee company, Guiyang Pharmaceutical E-commerce, reported a net profit of 6.47 million yuan Information on Major Investee Companies | Company Name | Main Product or Service | Net Profit (Yuan) | | :--- | :--- | :--- | | Guiyang Pharmaceutical E-commerce Service Co, Ltd | Distribution of pharmaceuticals and medical devices | 6,467,355.02 | [Progress and Impact of Major R&D Projects](index=18&type=section&id=7%E3%80%81%E9%87%8D%E8%A6%81%E7%A0%94%E5%8F%91%E9%A1%B9%E7%9B%AE%E7%9A%84%E8%BF%9B%E5%B1%95%E5%8F%8A%E5%BD%B1%E5%93%8D) The company had no significant R&D project developments to disclose for the reporting period - The company had no significant progress or impact from R&D projects during the reporting period[48](index=48&type=chunk) [Analysis of Adverse Changes in Core Competitiveness](index=18&type=section&id=8%E3%80%81%E6%A0%B8%E5%BF%83%E7%AB%9E%E4%BA%89%E5%8A%9B%E4%B8%8D%E5%88%A9%E5%8F%98%E5%8C%96%E5%88%86%E6%9E%90) The company's core competitiveness did not experience any adverse changes during the reporting period - The company reported no adverse changes to its core competitiveness during the reporting period[48](index=48&type=chunk) [Macroeconomic Environment and Industry Position Trends](index=18&type=section&id=9%E3%80%81%E5%85%AC%E5%8F%B8%E4%B8%9A%E5%8A%A1%E7%9B%B8%E5%85%B3%E7%9A%84%E5%AE%8F%E8%A7%82%E7%BB%8F%E6%B5%8E%E5%B1%82%E9%9D%A2%E6%88%96%E5%A4%96%E9%83%A8%E7%BB%8F%E8%90%A5%E7%8E%AF%E5%A2%83%E7%9A%84%E5%8F%91%E5%B1%95%E7%8E%B0%E7%8A%B6%E5%92%8C%E5%8F%98%E5%8C%96%E8%B6%8B%E5%8A%BF%E5%8F%8A%E5%85%AC%E5%8F%B8%E8%A1%8C%E4%B8%9A%E5%9C%B0%E4%BD%8D%E6%88%96%E5%8C%BA%E5%9F%9F%E5%B8%82%E5%9C%BA%E5%9C%B0%E4%BD%8D%E7%9A%84%E5%8F%98%E5%8A%A8%E8%B6%8B%E5%8A%BF) The company is actively positioning itself in the increasingly competitive internet healthcare market, leveraging its unique strengths - China's aging population and healthcare reforms have made the healthcare and internet healthcare sectors investment hotspots, attracting major players like BAT and intensifying competition[48](index=48&type=chunk) - The company leverages the complementary strengths of its internet and medical teams to actively advance its internet healthcare development strategy[48](index=48&type=chunk) - The company was named a **Top 100 Internet Enterprise** by the MIIT and the Internet Society of China, being the only internet healthcare company on the list[48](index=48&type=chunk) [Execution of Annual Business Plan](index=19&type=section&id=10%E3%80%81%E5%85%AC%E5%8F%B8%E5%B9%B4%E5%BA%A6%E7%BB%8F%E8%90%A5%E8%AE%A1%E5%88%92%E5%9C%A8%E6%8A%A5%E5%91%8A%E6%9C%9F%E5%86%85%E7%9A%84%E6%89%A7%E8%A1%8C%E6%83%85%E5%86%B5) The company achieved revenue of 189 million yuan and net profit of 39.13 million yuan, showing steady growth - Operating revenue for the period was **189.52 million yuan, a year-over-year increase of 20.36%**, mainly due to the consolidation of 46.19 million yuan from Sixth People's Hospital and 13.62 million yuan from the new mobile resale business[49](index=49&type=chunk) - Net profit attributable to shareholders was **39.13 million yuan, a year-over-year increase of 12.12%**, driven by steady growth in business profits[49](index=49&type=chunk) [Risk Factors and Countermeasures](index=19&type=section&id=11%E3%80%81%E5%AF%B9%E5%85%AC%E5%8F%B8%E6%9C%AA%E6%9D%A5%E5%8F%91%E5%B1%95%E6%88%98%E7%95%A5%E5%92%8C%E7%BB%8F%E8%90%A5%E7%9B%AE%E6%A0%87%E7%9A%84%E5%AE%9E%E7%8E%B0%E4%BA%A7%E7%94%9F%E4%B8%8D%E5%88%A9%E5%BD%B1%E5%93%8D%E7%9A%84%E9%A3%8E%E9%99%A9%E5%9B%A0%E7%B4%A0%E5%8F%8A%E5%85%AC%E5%8F%B8%E9%87%87%E5%8F%96%E7%9A%84%E6%8E%AA%E6%96%BD) The company is mitigating risks by aligning with policy, strengthening core businesses, and securing diverse funding sources - The company closely follows policy trends, pioneering public hospital reform and acquisitions to develop its internet hospital business in line with national tiered-care policies[50](index=50&type=chunk) - The company enhances its risk resilience by strengthening its core businesses (eg, 39 Health Net, Sixth People's Hospital, and the acquisition of Kangxin Pharmaceutical by its e-commerce arm) to steadily improve profitability[50](index=50&type=chunk) - The company actively seeks financing from the primary market and other channels to mitigate the operational risks associated with its high-risk internet healthcare ventures[50](index=50&type=chunk) [Investment Analysis](index=19&type=section&id=%E4%BA%8C%E3%80%81%E6%8A%95%E8%B5%84%E7%8A%B6%E5%86%B5%E5%88%86%E6%9E%90) The company utilized 271 million yuan of raised funds, with 50.10% repurposed, and invested non-raised funds in acquiring Sixth People's Hospital [Use of Raised Funds](index=19&type=section&id=1%E3%80%81%E5%8B%9F%E9%9B%86%E8%B5%84%E9%87%91%E4%BD%BF%E7%94%A8%E6%83%85%E5%86%B5) Of the 275 million yuan in total raised funds, 138 million yuan was repurposed, primarily for an equity acquisition Overall Use of Raised Funds | Indicator | Amount (10,000 Yuan) | | :--- | :--- | | Total Raised Funds | 27,541.13 | | Raised Funds Invested in the Reporting Period | 15.93 | | Cumulative Raised Funds Invested | 27,179.2 | | Raised Funds with Changed Purpose in the Reporting Period | 0 | | Cumulative Raised Funds with Changed Purpose | 13,797.3 | | Percentage of Cumulative Raised Funds with Changed Purpose | 50.10% | - The remaining balance of raised funds is **3.62 million yuan**, with the discrepancy from unused funds due to net interest income after deducting fees[53](index=53&type=chunk) - Several committed investment projects were repurposed, with funds primarily used for the acquisition of Guangzhou Qisheng Information Technology Co, Ltd[55](index=55&type=chunk)[56](index=56&type=chunk)[57](index=57&type=chunk)[60](index=60&type=chunk)[61](index=61&type=chunk) - **Excess funds of 38.47 million yuan** were fully invested in the phone+ mobile internet multi-party voice system project, which is now operational[56](index=56&type=chunk)[57](index=57&type=chunk) [Major Projects Using Non-raised Funds](index=25&type=section&id=2%E3%80%81%E9%9D%9E%E5%8B%9F%E9%9B%86%E8%B5%84%E9%87%91%E6%8A%95%E8%B5%84%E7%9A%84%E9%87%8D%E5%A4%A7%E9%A1%B9%E7%9B%AE%E6%83%85%E5%86%B5) The primary non-raised fund investment was the 141 million yuan capital increase to control Sixth People's Hospital Major Projects Using Non-raised Funds | Project Name | Planned Investment (10,000 Yuan) | Investment this Period (10,000 Yuan) | Cumulative Investment to Date (10,000 Yuan) | Cumulative Return to Date (10,000 Yuan) | Disclosure Date (if any) | Disclosure Index (if any) | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | Capital Increase and Control of Sixth People's Hospital | 14,104.54 | 2,000 | 2,000 | -157.74 | 2016-02-04 | See "Major Asset Purchase Implementation Report" on cninfo.com.cn | | **Total** | **14,104.54** | **2,000** | **2,000** | **-157.74** | | | [External Equity Investments](index=25&type=section&id=3%E3%80%81%E5%AF%B9%E5%A4%96%E8%82%A1%E6%9D%83%E6%8A%95%E8%B5%84%E6%83%85%E5%86%B5) The company held no equity in other listed companies or financial enterprises during the reporting period - The company did not hold equity in other listed companies during the reporting period[63](index=63&type=chunk) - The company did not hold equity in financial enterprises during the reporting period[63](index=63&type=chunk) [Entrusted Wealth Management, Derivatives, and Loans](index=25&type=section&id=4%E3%80%81%E5%A7%94%E6%89%98%E7%90%86%E8%B4%A2%E3%80%81%E8%A1%8D%E7%94%9F%E5%93%81%E6%8A%95%E8%B5%84%E5%92%8C%E5%A7%94%E6%89%98%E8%B4%B7%E6%AC%BE%E6%83%85%E5%86%B5) The company did not engage in entrusted wealth management, derivatives investment, or entrusted loans during the reporting period - The company had no entrusted wealth management during the reporting period[64](index=64&type=chunk) - The company had no derivatives investments during the reporting period[65](index=65&type=chunk) - The company had no entrusted loans during the reporting period[66](index=66&type=chunk) [Realization of Profit Forecasts, Plans, or Outlooks](index=26&type=section&id=%E4%B8%89%E3%80%81%E6%9C%89%E5%85%B3%E7%9B%88%E5%88%A9%E9%A2%84%E6%B5%8B%E3%80%81%E8%AE%A1%E5%88%92%E6%88%96%E5%B1%95%E6%9C%9B%E7%9A%84%E5%AE%9E%E7%8E%B0%E6%83%85%E5%86%B5) The company had no profit forecasts, plans, or outlooks to report on for the period - The company had no realization of profit forecasts, plans, or outlooks during the reporting period[67](index=67&type=chunk) [Warning of Potential Losses or Significant Profit Fluctuations](index=26&type=section&id=%E5%9B%9B%E3%80%81%E9%A2%84%E6%B5%8B%E5%B9%B4%E5%88%9D%E8%87%B3%E4%B8%8B%E4%B8%80%E6%8A%A5%E5%91%8A%E6%9C%9F%E6%9C%9F%E6%9C%AB%E7%9A%84%E7%B4%AF%E8%AE%A1%E5%87%80%E5%88%A9%E6%B6%A6%E5%8F%AF%E8%83%BD%E4%B8%BA%E4%BA%8F%E6%8D%9F%E3%80%81%E5%AE%9E%E7%8E%B0%E6%89%AD%E4%BA%8F%E4%B8%BA%E7%9B%88%E6%88%96%E8%80%85%E4%B8%8E%E4%B8%8A%E5%B9%B4%E5%90%8C%E6%9C%9F%E7%9B%B8%E6%AF%94%E5%8F%91%E7%94%9F%E5%A4%A7%E5%B9%85%E5%BA%A6%E5%8F%98%E5%8A%A8%E7%9A%84%E8%AD%A6%E7%A4%BA%E5%8F%8A%E5%8E%9F%E5%9B%A0%E8%AF%B4%E6%98%8E) The company issued no warnings regarding potential losses, turnarounds, or significant profit fluctuations - The company had no warnings of potential losses, turnarounds, or significant profit fluctuations from the beginning of the year to the end of the next reporting period[67](index=67&type=chunk) [Board's Explanation of "Non-standard Audit Report"](index=26&type=section&id=%E4%BA%94%E3%80%81%E8%91%A3%E4%BA%8B%E4%BC%9A%E3%80%81%E7%9B%91%E4%BA%8B%E4%BC%9A%E5%AF%B9%E4%BC%9A%E8%AE%A1%E5%B8%88%E4%BA%8B%E5%8A%A1%E6%89%80%E6%9C%AC%E6%8A%A5%E5%91%8A%E6%9C%9F%22%E9%9D%9E%E6%A0%87%E5%87%86%E5%AE%A1%E8%AE%A1%E6%8A%A5%E5%91%8A%22%E7%9A%84%E8%AF%B4%E6%98%8E) The semi-annual financial report was unaudited, thus no non-standard audit report explanation is applicable - The company's semi-annual report was unaudited[67](index=67&type=chunk) [Board's Explanation of Prior Year's "Non-standard Audit Report"](index=26&type=section&id=%E5%85%AD%E3%80%81%E8%91%A3%E4%BA%8B%E4%BC%9A%E5%AF%B9%E4%B8%8A%E5%B9%B4%E5%BA%A6%22%E9%9D%9E%E6%A0%87%E5%87%86%E5%AE%A1%E8%AE%A1%E6%8A%A5%E5%91%8A%22%E7%9B%B8%E5%85%B3%E6%83%85%E5%86%B5%E7%9A%84%E8%AF%B4%E6%98%8E) The Board of Directors has no explanation regarding a "non-standard audit report" from the previous year - The Board of Directors has no explanation regarding a "non-standard audit report" from the previous year[67](index=67&type=chunk) [Implementation of Profit Distribution Plan](index=26&type=section&id=%E4%B8%83%E3%80%81%E6%8A%A5%E5%91%8A%E6%9C%9F%E5%86%85%E5%85%AC%E5%8F%B8%E5%88%A9%E6%B6%A6%E5%88%86%E9%85%8D%E6%96%B9%E6%A1%88%E5%AE%9E%E6%96%BD%E6%83%85%E5%86%B5) No dividends were distributed as profits were retained to fund investments in the internet healthcare business - The profit distribution plan for the previous year was **no cash dividends, no bonus shares, and no conversion of capital reserves into share capital**[67](index=67&type=chunk) - Although the company was profitable and the parent company had positive retained earnings, no cash dividend plan was proposed due to significant capital requirements for further investment in the internet healthcare business in 2016[68](index=68&type=chunk) - Available profits will be used for company development and retained for future distribution[68](index=68&type=chunk) [Profit Distribution and Capitalization Plan for the Current Period](index=27&type=section&id=%E5%85%AB%E3%80%81%E6%9C%AC%E6%8A%A5%E5%91%8A%E6%9C%9F%E5%88%A9%E6%B6%A6%E5%88%86%E9%85%8D%E5%8F%8A%E8%B5%84%E6%9C%AC%E5%85%AC%E7%A7%AF%E9%87%91%E8%BD%AC%E5%A2%9E%E8%82%A1%E6%9C%AC%E9%A2%84%E6%A1%88) The company does not plan to distribute dividends or capitalize reserves for the semi-annual period - The company plans **no cash dividends, no bonus shares, and no conversion of capital reserves into share capital** for the semi-annual period[69](index=69&type=chunk) [Significant Matters](index=28&type=section&id=%E7%AC%AC%E5%9B%9B%E8%8A%82%20%E9%87%8D%E8%A6%81%E4%BA%8B%E9%A1%B9) [Major Litigation and Arbitration](index=28&type=section&id=%E4%B8%80%E3%80%81%E9%87%8D%E5%A4%A7%E8%AF%89%E8%AE%BC%E4%BB%B2%E8%A3%81%E4%BA%8B%E9%A1%B9) The company had no major litigation or arbitration matters during the reporting period - The company had no major litigation or arbitration matters during this reporting period[72](index=72&type=chunk) [Asset Transactions](index=28&type=section&id=%E4%BA%8C%E3%80%81%E8%B5%84%E4%BA%A7%E4%BA%A4%E6%98%93%E4%BA%8B%E9%A1%B9) The company completed investments in Sichuan Laya and Sixth People's Hospital, with the latter now consolidated [Asset Acquisitions](index=28&type=section&id=1%E3%80%81%E6%94%B6%E8%B4%AD%E8%B5%84%E4%BA%A7%E6%83%85%E5%86%B5) The company acquired a 19.9% stake in Sichuan Laya and a controlling 66% stake in Sixth People's Hospital Asset Acquisition Details | Counterparty or Ultimate Controller | Acquired Asset | Transaction Price (10,000 Yuan) | Progress | Related-Party Transaction | | :--- | :--- | :--- | :--- | :--- | | Guo Jinhong, Wang Xiang | 19.9% stake in Sichuan Laya | 1,000 | Business registration change completed | No | | Medical Management Group | 66% stake in Sixth People's Hospital | 14,104.54 | Business registration changed; consolidated into financial statements from Jan 1, 2016 | No | [Asset Sales](index=29&type=section&id=2%E3%80%81%E5%87%BA%E5%94%AE%E8%B5%84%E4%BA%A7%E6%83%85%E5%86%B5) The company did not sell any assets during the reporting period - The company did not sell any assets during the reporting period[74](index=74&type=chunk) [Business Combinations](index=29&type=section&id=3%E3%80%81%E4%BC%81%E4%B8%9A%E5%90%88%E5%B9%B6%E6%83%85%E5%86%B5) The company did not engage in any business combinations during the reporting period - The company did not engage in any business combinations during the reporting period[75](index=75&type=chunk) [Implementation of Equity Incentive Plans](index=29&type=section&id=%E4%B8%89%E3%80%81%E5%85%AC%E5%8F%B8%E8%82%A1%E6%9D%83%E6%BF%80%E5%8A%B1%E7%9A%84%E5%AE%9E%E6%96%BD%E6%83%85%E5%86%B5%E5%8F%8A%E5%85%B6%E5%BD%B1%E5%93%8D) The company had no equity incentive plans or related implementations during the reporting period - The company had no equity incentive plans or related implementations during the reporting period[75](index=75&type=chunk) [Significant Related-Party Transactions](index=29&type=section&id=%E5%9B%9B%E3%80%81%E9%87%8D%E5%A4%A7%E5%85%B3%E8%81%94%E4%BA%A4%E6%98%93) The company engaged in related-party transactions involving the establishment and capital increase of Guiyang 39 Internet Hospital [Related-Party Transactions in Daily Operations](index=29&type=section&id=1%E3%80%81%E4%B8%8E%E6%97%A5%E5%B8%B8%E7%BB%8F%E8%90%A5%E7%9B%B8%E5%85%B3%E7%9A%84%E5%85%B3%E8%81%94%E4%BA%A4%E6%98%93) A cooperative operational agreement with a related party had no financial impact during the period Related-Party Transactions in Daily Operations | Related Party | Relationship | Transaction Type | Transaction Content | Transaction Amount (10,000 Yuan) | % of Similar Transactions | Approved Limit (10,000 Yuan) | Exceeded Limit | Impact on Company Profit | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | Guiyang 39 Internet Hospital Co, Ltd | Under common control | Daily operational cooperation | Cooperative operation of internet-based secondary diagnosis for complex cases | 0 | | 0 | No | No impact | [Related-Party Transactions in Asset Acquisitions and Sales](index=30&type=section&id=2%E3%80%81%E8%B5%84%E4%BA%A7%E6%94%B6%E8%B4%AD%E3%80%81%E5%87%BA%E5%94%AE%E5%8F%91%E7%94%9F%E7%9A%84%E5%85%B3%E8%81%94%E4%BA%A4%E6%98%93) The company had no related-party transactions involving asset acquisitions or sales during the reporting period - The company had no related-party transactions involving asset acquisitions or sales during the reporting period[78](index=78&type=chunk) [Related-Party Debts and Credits](index=30&type=section&id=3%E3%80%81%E5%85%B3%E8%81%94%E5%80%BA%E6%9D%83%E5%80%BA%E5%8A%A1%E5%BE%80%E6%9D%A5) The company had no related-party debts or credits during the reporting period - The company had no related-party debts or credits during the reporting period[79](index=79&type=chunk) [Other Significant Related-Party Transactions](index=30&type=section&id=4%E3%80%81%E5%85%B6%E4%BB%96%E9%87%8D%E5%A4%A7%E5%85%B3%E8%81%94%E4%BA%A4%E6%98%93) The company participated in the establishment and capital increase of Guiyang 39 Internet Hospital, constituting related-party transactions - The company participated in establishing Guiyang 39 Internet Hospital Co, Ltd, subscribing **1.99 million yuan for a 19.9% stake**, which constitutes a related-party transaction as Wang Wei is the company's controlling shareholder[80](index=80&type=chunk) - The company invested an additional **15 million yuan** to increase its stake in Guiyang 39 Internet Hospital to **20.91%**, which also constitutes a related-party transaction due to the involvement of company executives and the controlling shareholder[81](index=81&type=chunk)[82](index=82&type=chunk) [Significant Contracts and Their Performance](index=31&type=section&id=%E4%BA%94%E3%80%81%E9%87%8D%E5%A4%A7%E5%90%88%E5%90%8C%E5%8F%8A%E5%85%B6%E5%B1%A5%E8%A1%8C%E6%83%85%E5%86%B5) The company has ongoing property lease agreements but no other significant contracts such as custody, contracting, or guarantees [Custody, Contracting, and Leasing](index=31&type=section&id=1%E3%80%81%E6%89%98%E7%AE%A1%E3%80%81%E6%89%BF%E5%8C%85%E3%80%81%E7%A7%9F%E8%B5%81%E4%BA%8B%E9%A1%B9%E6%83%85%E5%86%B5) The company has two major office lease agreements in Guangzhou and Beijing, with no custody or contracting arrangements - The company had no custody arrangements during the reporting period[83](index=83&type=chunk) - The company had no contracting arrangements during the reporting period[84](index=84&type=chunk) - Qisheng Information leases office space in Guangzhou with a monthly rent of **490,695.52 yuan** until August 31, 2017[85](index=85&type=chunk)[86](index=86&type=chunk) - The company leases office space in Beijing with an annual rent of **3,609,612.00 yuan** until October 31, 2016[86](index=86&type=chunk) - No leasing activities generated profits or losses exceeding 10% of the company's total profit for the reporting period[87](index=87&type=chunk) [Guarantees](index=32&type=section&id=2%E3%80%81%E6%8B%85%E4%BF%9D%E6%83%85%E5%86%B5) The company had no guarantee arrangements during the reporting period - The company had no guarantee arrangements during the reporting period[88](index=88&type=chunk) [Significant Entrusted Cash Management](index=32&type=section&id=3%E3%80%81%E9%87%8D%E5%A4%A7%E5%A7%94%E6%89%98%E4%BB%96%E4%BA%BA%E8%BF%9B%E8%A1%8C%E7%8E%B0%E9%87%91%E8%B5%84%E4%BA%A7%E7%AE%A1%E7%90%86%E6%83%85%E5%86%B5) The company had no significant entrusted cash management activities during the reporting period - The company had no significant entrusted cash management activities during the reporting period[89](index=89&type=chunk) [Other Significant Contracts](index=32&type=section&id=4%E3%80%81%E5%85%B6%E4%BB%96%E9%87%8D%E5%A4%A7%E5%90%88%E5%90%8C) The company had no other significant contracts during the reporting period - The company had no other significant contracts during the reporting period[89](index=89&type=chunk) [Commitments from the Company or Shareholders with over 5% Stake](index=32&type=section&id=%E5%85%AD%E3%80%81%E5%85%AC%E5%8F%B8%E6%88%96%E6%8C%81%E8%82%A1%205%25%E4%BB%A5%E4%B8%8A%E8%82%A1%E4%B8%9C%E5%9C%A8%E6%8A%A5%E5%91%8A%E6%9C%9F%E5%86%85%E5%8F%91%E7%94%9F%E6%88%96%E4%BB%A5%E5%89%8D%E6%9C%9F%E9%97%B4%E5%8F%91%E7%94%9F%E4%BD%86%E6%8C%81%E7%BB%AD%E5%88%B0%E6%8A%A5%E5%91%8A%E6%9C%9F%E5%86%85%E7%9A%84%E6%89%BF%E8%AF%BA%E4%BA%8B%E9%A1%B9) All commitments, including profit compensation, share lock-ups, and non-competition, are being strictly fulfilled - During the asset restructuring, committing parties guaranteed that the target company's net profit after non-recurring items for 2014-2016 would be no less than **45 million, 55 million, and 65 million yuan**, respectively, with a compensation obligation for any shortfall[91](index=91&type=chunk) - Shares held by key employees such as Gu Jing and Zhang Mengyou are subject to lock-up periods of varying lengths, up to 36 months[91](index=91&type=chunk) - Controlling shareholder Wang Wei and related parties committed not to transfer shares for 36 months from the listing date and issued a **Non-Competition Commitment Letter**[91](index=91&type=chunk)[92](index=92&type=chunk) - Directors, supervisors, and senior management committed not to transfer shares for 36 months from the listing date and to limit annual transfers to **25% of their total holdings** during their tenure[91](index=91&type=chunk)[92](index=92&type=chunk) - All commitments have been fulfilled in a timely manner[92](index=92&type=chunk) [Appointment and Dismissal of Accounting Firm](index=35&type=section&id=%E4%B8%83%E3%80%81%E8%81%98%E4%BB%BB%E3%80%81%E8%A7%A3%E8%81%98%E4%BC%9A%E8%AE%A1%E5%B8%88%E4%BA%8B%E5%8A%A1%E6%89%80%E6%83%85%E5%86%B5) The company's semi-annual financial report was not audited - The company's semi-annual report was unaudited[93](index=93&type=chunk) [Other Significant Matters](index=35&type=section&id=%E5%85%AB%E3%80%81%E5%85%B6%E4%BB%96%E9%87%8D%E5%A4%A7%E4%BA%8B%E9%A1%B9%E7%9A%84%E8%AF%B4%E6%98%8E) The company terminated a private placement, advanced a major acquisition by a subsidiary, and withdrew from sponsoring a private bank - The company terminated its non-public offering of shares to focus on its internet healthcare business and explore alternative financing methods[94](index=94&type=chunk)[95](index=95&type=chunk) - The affiliated company, Pharmaceutical E-commerce, plans to increase its capital by approximately **98 million yuan** and acquire a controlling stake in a large pharmaceutical distribution company[97](index=97&type=chunk) - The company decided not to act as the main sponsor for Gui'an Technology Bank due to an increased minimum capital requirement and its strategic shift to internet healthcare[97](index=97&type=chunk) [Share Capital Changes and Shareholders](index=37&type=section&id=%E7%AC%AC%E4%BA%94%E8%8A%82%20%E8%82%A1%E4%BB%BD%E5%8F%98%E5%8A%A8%E5%8F%8A%E8%82%A1%E4%B8%9C%E6%83%85%E5%86%B5) [Share Capital Changes](index=37&type=section&id=%E4%B8%80%E3%80%81%E8%82%A1%E4%BB%BD%E5%8F%98%E5%8A%A8%E6%83%85%E5%86%B5) The total number of shares remained unchanged, while restricted shares decreased due to lock-up expirations [Share Capital Changes](index=37&type=section&id=1%E3%80%81%E8%82%A1%E4%BB%BD%E5%8F%98%E5%8A%A8%E6%83%85%E5%86%B5) Total shares remained at 337.9 million, with a shift of 6.48 million shares from restricted to unrestricted status Share Capital Changes | Share Type | Pre-Change Quantity (Shares) | Pre-Change Ratio | Change (+, -) (Shares) | Post-Change Quantity (Shares) | Post-Change Ratio | | :--- | :--- | :--- | :--- | :--- | :--- | | I. Restricted Shares | 174,753,402 | 51.71% | -6,475,350 | 168,278,052 | 49.93% | | 3. Other Domestic Holdings | 174,753,402 | 51.71% | -6,475,350 | 168,278,052 | 49.93% | | Domestic Individual Holdings | 174,753,402 | 51.71% | -6,475,350 | 168,278,052 | 49.93% | | II. Unrestricted Shares | 163,188,000 | 48.29% | 6,475,350 | 169,663,350 | 50.07% | | 1. RMB Ordinary Shares | 163,188,000 | 48.29% | 6,475,350 | 169,663,350 | 50.07% | | III. Total Shares | 337,941,402 | 100.00% | 0 | 337,941,402 | 100.00% | - Executive lock-up shares decreased by **393,375** due to a recalculation of the annual transferable quota[102](index=102&type=chunk) - Restricted shares from a major asset restructuring were released, totaling **6,081,975 shares**[103](index=103&type=chunk) [Changes in Restricted Shares](index=38&type=section&id=2%E3%80%81%E9%99%90%E5%94%AE%E8%82%A1%E4%BB%BD%E5%8F%98%E5%8A%A8%E6%83%85%E5%86%B5) A total of 6.48 million restricted shares were released, primarily from executive lock-ups and post-offering individual holdings Changes in Restricted Shares | Shareholder Name | Initial Restricted Shares (Shares) | Shares Released this Period (Shares) | Ending Restricted Shares (Shares) | Reason for Restriction | Planned Release Date | | :--- | :--- | :--- | :--- | :--- | :--- | | Wang Wei | 91,872,000 | 0 | 91,872,000 | Executive Lock-up | January 1 annually | | Huang Guohong | 24,840,000 | 0 | 24,840,000 | Executive Lock-up | January 1 annually | | Jin Guowen | 20,880,000 | 393,375 | 20,486,625 | Executive Lock-up | January 1 annually | | Liu Ling | 14,040,000 | 0 | 14,040,000 | Executive Lock-up | January 1 annually | | Shi Hongjun | 5,580,000 | 0 | 5,580,000 | Executive Lock-up | January 1 annually | | Gu Jing | 9,319,938 | 2,055,882 | 7,264,056 | Post-offering Individual Lock-up | January 8, 2018 | | Zhang Mengyou | 8,052,186 | 4,026,093 | 4,026,093 | Post-offering Individual Lock-up | 2,013,046 shares on Jan 8, 2017; 2,013,047 shares on Jan 8, 2018 | | **Total** | **174,753,402** | **6,475,350** | **168,278,052** | | | [Number of Shareholders and Shareholdings](index=39&type=section&id=%E4%BA%8C%E3%80%81%E5%85%AC%E5%8F%B8%E8%82%A1%E4%B8%9C%E6%95%B0%E9%87%8F%E5%8F%8A%E6%8C%81%E8%82%A1%E6%83%85%E5%86%B5) The company had 26,098 shareholders, with Wang Wei being the largest, holding a 36.25% stake - The total number of shareholders at the end of the reporting period was **26,098**[108](index=108&type=chunk) Shareholdings of Shareholders with over 5% Stake | Shareholder Name | Shareholder Type | Shareholding Ratio | Shares Held at Period-End (Shares) | Restricted Shares Held (Shares) | Unrestricted Shares Held (Shares) | Pledged or Frozen Status | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | Wang Wei | Domestic Individual | 36.25% | 122,496,000 | 91,872,000 | 30,624,000 | | | Huang Guohong | Domestic Individual | 9.80% | 33,120,000 | 24,840,000 | 8,280,000 | | | Jin Guowen | Domestic Individual | 8.08% | 27,315,500 | 20,486,625 | 6,828,875 | | | Liu Ling | Domestic Individual | 5.01% | 16,920,000 | 14,040,000 | 2,880,000 | | - Gu Jing holds a 2.15% stake, of which **2,000,000 shares are pledged**[109](index=109&type=chunk) - The corporate shareholder, Guiyang Longmaster Investment Consulting Enterprise (Limited Partnership), is controlled by the company's controlling shareholder, Wang Wei, and they are parties acting in concert[109](index=109&type=chunk) [Changes in Controlling Shareholder or De Facto Controller](index=41&type=section&id=%E4%B8%89%E3%80%81%E6%8E%A7%E8%82%A1%E8%82%A1%E4%B8%9C%E6%88%96%E5%AE%9E%E9%99%85%E6%8E%A7%E5%88%B6%E4%BA%BA%E5%8F%98%E6%9B%B4%E6%83%85%E5%86%B5) The company's controlling shareholder and de facto controller remained unchanged during the reporting period - The company's controlling shareholder did not change during the reporting period[111](index=111&type=chunk) - The company's de facto controller did not change during the reporting period[112](index=112&type=chunk) [Directors, Supervisors, and Senior Management](index=42&type=section&id=%E7%AC%AC%E5%85%AD%E8%8A%82%20%E8%91%A3%E4%BA%8B%E3%80%81%E7%9B%91%E4%BA%8B%E3%80%81%E9%AB%98%E7%BA%A7%E7%AE%A1%E7%90%86%E4%BA%BA%E5%91%98%E6%83%85%E5%86%B5) [Shareholdings of Directors, Supervisors, and Senior Management](index=42&type=section&id=%E4%B8%80%E3%80%81%E8%91%A3%E4%BA%8B%E3%80%81%E7%9B%91%E4%BA%8B%E5%92%8C%E9%AB%98%E7%BA%A7%E7%AE%A1%E7%90%86%E4%BA%BA%E5%91%98%E6%8C%81%E6%9C%89%E6%9C%AC%E5%85%AC%E5%8F%B8%E8%82%A1%E4%BB%BD%E5%8F%8A%E8%82%A1%E7%A5%A8%E6%9C%9F%E6%9D%83%E6%83%85%E5%86%B5) Key management held a total of 207 million shares, with some members reducing their holdings during the period Shareholdings of Directors, Supervisors, and Senior Management | Name | Title | Status | Initial Shares (Shares) | Shares Sold this Period (Shares) | Ending Shares (Shares) | | :--- | :--- | :--- | :--- | :--- | :--- | | Wang Wei | Chairman | Current | 122,496,000 | 0 | 122,496,000 | | Huang Guohong | Director, General Manager | Current | 33,120,000 | 0 | 33,120,000 | | Jin Guowen | Director, Deputy GM | Current | 27,315,500 | 0 | 27,315,500 | | Liu Ling | Director | Current | 18,720,000 | 1,800,000 | 16,920,000 | | Shi Hongjun | Chairman of Supervisory Committee | Current | 7,440,000 | 300,000 | 7,140,000 | | **Total** | | | **209,091,500** | **2,100,000** | **206,991,500** | - The company had no stock option plans[116](index=116&type=chunk) [Changes in Directors, Supervisors, and Senior Management](index=43&type=section&id=%E4%BA%8C%E3%80%81%E5%85%AC%E5%8F%B8%E8%91%A3%E4%BA%8B%E3%80%81%E7%9B%91%E4%BA%8B%E3%80%81%E9%AB%98%E7%BA%A7%E7%AE%A1%E7%90%86%E4%BA%BA%E5%91%98%E5%8F%98%E5%8A%A8%E6%83%85%E5%86%B5) Employee supervisor Zang Fei resigned due to a work transfer and was replaced by the newly elected Chen Zhengchao Changes in Directors, Supervisors, and Senior Management | Name | Title | Type | Date | Reason | | :--- | :--- | :--- | :--- | :--- | | Zang Fei | Employee Supervisor | Resigned | 2016-04-18 | Work transfer | | Chen Zhengchao | Employee Supervisor | Elected | 2016-04-18 | Elected by employee representative congress | [Financial Report](index=44&type=section&id=%E7%AC%AC%E4%B8%83%E8%8A%82%20%E8%B4%A2%E5%8A%A1%E6%8A%A5%E5%91%8A) [Audit Report](index=44&type=section&id=%E4%B8%80%E3%80%81%E5%AE%A1%E8%AE%A1%E6%8A%A5%E5%91%8A) The semi-annual financial report was not audited - The company's semi-annual financial report was unaudited[119](index=119&type=chunk) [Financial Statements](index=44&type=section&id=%E4%BA%8C%E3%80%81%E8%B4%A2%E5%8A%A1%E6%8A%A5%E8%A1%A8) This section presents the company's financial statements, detailing its financial position, performance, and cash flows - The consolidated balance sheet shows **total assets of 1.28 billion yuan**, with current assets of 455 million yuan and non-current assets of 824 million yuan[121](index=121&type=chunk)[122](index=122&type=chunk) - The consolidated income statement shows **total operating revenue of 189 million yuan**, net profit of 35.84 million yuan, and net profit attributable to parent company owners of 39.13 million yuan[129](index=129&type=chunk)[131](index=131&type=chunk) - The consolidated cash flow statement shows **net cash from operating activities of 35.02 million yuan**, net cash used in investing activities of -111 million yuan, and net cash used in financing activities of -30.09 million yuan[139](index=139&type=chunk)[140](index=140&type=chunk) [Consolidated Balance Sheet](index=44&type=section&id=1%E3%80%81%E5%90%88%E5%B9%B6%E8%B5%84%E4%BA%A7%E8%B4%9F%E5%80%BA%E8%A1%A8) As of June 30, 2016, total consolidated assets were 1.28 billion yuan, a 6.00% increase from the beginning of the year Consolidated Balance Sheet (Ending Balance) | Item | Ending Balance (Yuan) | Opening Balance (Yuan) | | :--- | :--- | :--- | | Cash and Cash Equivalents | 304,822,772.35 | 410,549,920.27 | | Accounts Receivable | 75,749,297.05 | 57,044,068.99 | | Inventory | 6,875,424.61 | 423,253.83 | | Other Current Assets | 42,535,600.65 | 21,069,023.67 | | **Total Current Assets** | **455,242,396.14** | **507,529,583.68** | | Long-term Equity Investments | 51,818,499.49 | 19,693,864.13 | | Fixed Assets | 116,172,307.01 | 10,580,088.08 | | Construction in Progress | 0 | 64,555,495.84 | | Intangible Assets | 83,319,896.29 | 31,655,274.76 | | Goodwill | 570,624,696.82 | 570,624,696.82 | | **Total Non-current Assets** | **823,938,941.61** | **699,227,606.89** | | **Total Assets** | **1,279,181,337.75** | **1,206,757,190.57** | | Accounts Payable | 33,569,528.26 | 8,849,205.11 | | Advances from Customers | 21,750,356.32 | 11,804,451.73 | | Employee Benefits Payable | 18,015,740.44 | 12,706,724.70 | | Non-current Liabilities Due within One Year | 0 | 63,447,840.40 | | **Total Current Liabilities** | **117,245,972.02** | **147,866,456.33** | | Long-term Payables | 63,447,840.15 | 63,447,840.15 | | Deferred Income | 9,170,388.40 | 9,170,388.40 | | **Total Non-current Liabilities** | **72,618,228.55** | **72,649,514.95** | | **Total Liabilities** | **189,864,200.57** | **220,515,971.28** | | Share Capital | 337,941,402.00 | 337,941,402.00 | | Capital Reserve | 314,728,533.20 | 314,728,533.20 | | Retained Earnings | 338,528,884.43 | 299,394,985.57 | | Total Equity Attributable to Parent Company | 1,019,425,918.64 | 980,292,019.78 | | Minority Interests | 69,891,218.54 | 5,949,199.51 | | **Total Equity** | **1,089,317,137.18** | **986,241,219.29** | | **Total Liabilities and Equity** | **1,279,181,337.75** | **1,206,757,190.57** | [Parent Company Balance Sheet](index=47&type=section&id=2%E3%80%81%E6%AF%8D%E5%85%AC%E5%8F%B8%E8%B5%84%E4%BA%A7%E8%B4%9F%E5%80%BA%E8%A1%A8) As of June 30, 2016, the parent company's total assets were 1.14 billion yuan, a 2.26% increase from the beginning of the year Parent Company Balance Sheet (Ending Balance) | Item | Ending Balance (Yuan) | Opening Balance (Yuan) | | :--- | :--- | :--- | | Cash and Cash Equivalents | 200,026,166.63 | 263,996,112.97 | | Accounts Receivable | 32,313,801.41 | 33,333,396.43 | | Dividends Receivable | 40,000,000.00 | 0 | | **Total Current Assets** | **287,004,563.91** | **308,270,650.58** | | Long-term Equity Investments | 758,970,523.92 | 701,745,888.56 | | Fixed Assets | 64,546,650.03 | 7,195,226.89 | | Construction in Progress | 0 | 64,555,495.84 | | Intangible Assets | 26,343,503.59 | 29,691,448.28 | | **Total Non-current Assets** | **851,391,542.55** | **804,930,169.83** | | **Total Assets** | **1,138,396,106.46** | **1,113,200,820.41** | | Accounts Payable | 8,101,714.86 | 4,813,470.37 | | Advances from Customers | 16,306,424.30 | 6,180,625.75 | | Other Payables | 10,949,507.71 | 43,567,173.06 | | Non-current Liabilities Due within One Year | 0 | 63,447,840.40 | | **Total Current Liabilities** | **51,188,715.02** | **131,540,251.40** | | Long-term Payables | 63,447,840.15 | 63,447,840.15 | | Deferred Income | 8,067,055.18 | 8,067,055.18 | | **Total Non-current Liabilities** | **71,514,895.33** | **71,514,895.33** | | **Total Liabilities** | **122,703,610.35** | **203,055,146.73** | | Share Capital | 337,941,402.00 | 337,941,402.00 | | Capital Reserve | 321,973,281.82 | 321,973,281.82 | | Retained Earnings | 327,550,713.28 | 222,003,890.85 | | **Total Equity** | **1,015,692,496.11** | **910,145,673.68** | | **Total Liabilities and Equity** | **1,138,396,106.46** | **1,113,200,820.41** | [Consolidated Income Statement](index=50&type=section&id=3%E3%80%81%E5%90%88%E5%B9%B6%E5%88%A9%E6%B6%A6%E8%A1%A8) The company achieved a consolidated operating revenue of 189 million yuan and a net profit of 35.84 million yuan Consolidated Income Statement (Current Period) | Item | Current Period (Yuan) | Prior Period (Yuan) | | :--- | :--- | :--- | | I. Total Operating Revenue | 189,515,427.50 | 157,451,004.08 | | Including: Operating Revenue | 189,515,427.50 | 157,451,004.08 | | II. Total Operating Costs | 157,115,899.55 | 121,899,890.62 | | Including: Operating Costs | 76,182,990.61 | 45,665,206.85 | | Selling Expenses | 17,180,977.30 | 21,132,632.05 | | Administrative Expenses | 64,392,641.43 | 53,918,958.41 | | Finance Expenses | -2,778,013.98 | -2,883,797.54 | | Asset Impairment Loss | 205,099.78 | 2,284,097.58 | | Add: Investment Income (Losses in "-") | 758,351.96 | 5,088,256.94 | | III. Operating Profit (Losses in "-") | 33,157,879.91 | 40,639,370.40 | | Add: Non-operating Income | 11,195,084.16 | 3,534,297.46 | | Less: Non-operating Expenses | 31,574.85 | 111,232.65 | | IV. Total Profit (Total Losses in "-") | 44,321,389.22 | 44,062,435.21 | | Less: Income Tax Expense | 8,482,428.63 | 11,158,858.22 | | V. Net Profit (Net Losses in "-") | 35,838,960.59 | 32,903,576.99 | | Net Profit Attributable to Parent Company Owners | 39,133,898.86 | 34,903,170.71 | | Minority Interest Income/Loss | -3,294,938.27 | -1,999,593.72 | | VII. Total Comprehensive Income | 35,838,960.59 | 32,903,576.99 | | Total Comprehensive Income Attributable to Parent Company Owners | 39,133,898.86 | 34,903,170.71 | | VIII. Earnings Per Share: | | | | (I) Basic Earnings Per Share | 0.12 | 0.10 | | (II) Diluted Earnings Per Share | 0.12 | 0.10 | [Parent Company Income Statement](index=52&type=section&id=4%E3%80%81%E6%AF%8D%E5%85%AC%E5%8F%B8%E5%88%A9%E6%B6%A6%E8%A1%A8) The parent company reported operating revenue of 68.70 million yuan and a net profit of 105 million yuan Parent Company Income Statement (Current Period) | Item | Current Period (Yuan) | Prior Period (Yuan) | | :--- | :--- | :--- | | I. Operating Revenue | 68,700,240.86 | 84,399,065.10 | | Less: Operating Costs | 17,532,493.06 | 30,405,243.98 | | Selling Expenses | 9,212,589.01 | 10,248,074.75 | | Administrative Expenses | 43,213,570.76 | 39,974,814.12 | | Finance Expenses | -1,076,368.97 | -1,056,207.08 | | Asset Impairment Loss | 229,698.36 | 2,003,526.99 | | Add: Investment Income (Losses in "-") | 100,634,635.36 | 3,197,896.17 | | II. Operating Profit (Losses in "-") | 99,935,892.15 | 5,799,180.90 | | Add: Non-operating Income | 7,369,320.86 | 2,955,793.35 | | Less: Non-operating Expenses | 7,580.24 | 0 | | III. Total Profit (Total Losses in "-") | 107,297,632.77 | 8,754,974.25 | | Less: Income Tax Expense | 1,750,810.34 | 1,413,422.49 | | IV. Net Profit (Net Losses in "-") | 105,546,822.43 | 7,341,551.76 | | VI. Total Comprehensive Income | 105,546,822.43 | 7,341,551.76 | [Consolidated Cash Flow Statement](index=53&type=section&id=5%E3%80%81%E5%90%88%E5%B9%B6%E7%8E%B0%E9%87%91%E6%B5%81%E9%87%8F%E8%A1%A8) Operating cash flow was stable, while investing and financing activities resulted in a net cash outflow, decreasing total cash reserves Consolidated Cash Flow Statement (Current Period) | Item | Current Period (Yuan) | Prior Period (Yuan) | | :--- | :--- | :--- | | Cash Received from Sales of Goods and Services | 220,001,154.89 | 147,054,635.95 | | Other Cash Received Related to Operating Activities | 13,660,558.25 | 9,883,410.29 | | **Subtotal of Cash Inflows from Operating Activities** | **233,661,713.14** | **156,938,046.24** | | Cash Paid for Goods and Services | 63,801,251.05 | 7,894,961.11 | | Cash Paid to and for Employees | 70,885,951.73 | 44,695,739.69 | | Taxes and Surcharges Paid | 23,789,509.70 | 18,276,591.46 | | Other Cash Paid Related to Operating Activities | 40,163,357.04 | 50,967,239.88 | | **Subtotal of Cash Outflows from Operating Activities** | **198,640,069.52** | **121,834,532.14** | | **Net Cash Flow from Operating Activities** | **35,021,643.62** | **35,103,514.10** | | Cash Received from Return of Investments | 184,100,000.00 | 68,774,162.69 | | Cash Received from Investment Income | 123,716.60 | 1,053,601.46 | | Net Cash Received from Disposal of Fixed and Intangible Assets | 30.00 | 3,550.00 | | Other Cash Received Related to Investing Activities | 1,130,826.02 | 0 | | **Subtotal of Cash Inflows from Investing Activities** | **185,354,572.62** | **74,463,650.11** | | Cash Paid for Fixed and Intangible Assets | 1,692,971.84 | 7,559,110.17 | | Cash Paid for Investments | 294,324,392.32 | 170,668,055.34 | | **Subtotal of Cash Outflows from Investing Activities** | **296,017,364.16** | **178,227,165.51** | | **Net Cash Flow from Investing Activities** | **-110,662,791.54** | **-103,763,515.40** | | Cash Received from Investments | 0 | 30,000,000.00 | | Other Cash Paid Related to Financing Activities | 30,086,000.00 | 351,294.26 | | **Subtotal of Cash Outflows from Financing Activities** | **30,086,000.00** | **351,294.26** | | **Net Cash Flow from Financing Activities** | **-30,086,000.00** | **29,648,705.74** | | **Net Increase in Cash and Cash Equivalents** | **-105,727,147.92** | **-39,011,295.56** | [Parent Company Cash Flow Statement](index=56&type=section&id=6%E3%80%81%E6%AF%8D%E5%85%AC%E5%8F%B8%E7%8E%B0%E9%87%91%E6%B5%81%E9%87%8F%E8%A1%A8) The parent company's cash reserves decreased by 64 million yuan due to outflows from investing and financing activities Parent Company Cash Flow Statement (Current Period) | Item | Current Period (Yuan) | Prior Period (Yuan) | | :--- | :--- | :--- | | Cash Received from Sales of Goods and Services | 82,980,918.68 | 81,134,372.26 | | Other Cash Received Related to Operating Activities | 11,237,476.70 | 4,776,229.76 | | **Subtotal of Cash Inflows from Operating Activities** | **94,218,395.38** | **85,910,602.02** | | Cash Paid for Goods and Services | 13,094,216.26 | 3,242,951.58 | | Cash Paid to and for Employees | 29,542,918.21 | 27,596,324.43 | | Taxes and Surcharges Paid | 5,656,969.70 | 5,790,100.74 | | Other Cash Paid Related to Operating Activities | 20,083,532.52 | 36,742,319.63 | | **Subtotal of Cash Outflows from Operating Activities** | **68,377,636.69** | **73,371,696.38** | | **Net Cash Flow from Operating Activities** | **25,840,758.69** | **12,538,905.64** | | Cash Received from Return of Investments | 0 | 45,000,000.00 | | Cash Received from Investment Income | 60,000,000.00 | 0 | | **Subtotal of Cash Inflows from Investing Activities** | **60,000,030.00** | **45,000,000.00** | | Cash Paid for Fixed and Intangible Assets | 600,342.71 | 4,577,768.71 | | Cash Paid for Investments | 119,124,392.32 | 112,567,055.34 | | **Subtotal of Cash Outflows from Investing Activities** | **119,724,735.03** | **117,144,824.05** | | **Net Cash Flow from Investing Activities** | **-59,724,705.03** | **-72,144,824.05** | | Cash Received from Investments | 0 | 30,000,000.00 | | Other Cash Paid Related to Financing Activities | 30,086,000.00 | 351,294.26 | | **Subtotal of Cash Outflows from Financing Activities** | **30,086,000.00** | **351,294.26** | | **Net Cash Flow from Financing Activities** | **-30,086,000.00** | **29,648,705.74** | | **Net Increase in Cash and Cash Equivalents** | **-63,969,946.34** | **-29,957,212.67** | [Consolidated Statement of Changes in Equity](index=57&type=section&id=7%E3%80%81%E5%90%88%E5%B9%B6%E6%89%80%E6%9C%89%E8%80%85%E6%9D%83%E7%9B%8A%E5%8F%98%E5%8A%A8%E8%A1%A8) Total equity increased by 103 million yuan, driven by net profit and an increase in minority interests Consolidated Statement of Changes in Equity (Current Period) | Item | Share Capital (Yuan) | Capital Reserve (Yuan) | Surplus Reserve (Yuan) | Retained Earnings (Yuan) | Minority Interests (Yuan) | Total Equity (Yuan) | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | I. Balance at Prior Year-End | 337,941,402.00 | 314,728,533.20 | 28,227,099.01 | 299,394,985.57 | 5,949,199.51 | 986,241,219.29 | | II. Balance at Beginning of Year | 337,941,402.00 | 314,728,533.20 | 28,227,099.01 | 299,394,985.57 | 5,949,199.51 | 986,241,219.29 | | III. Changes this Period | 0 | 0 | 0 | 39,133,898.86 | 63,942,019.03 | 103,075,917.89 | | (I) Total Comprehensive Income | 0 | 0 | 0 | 39,133,898.86 | -3,294,938.27 | 35,838,960.59 | | (II) Capital Contributions and Reductions | 0 | 0 | 0 | 0 | 67,236,957.30 | 67,236,957.30 | | IV. Balance at Period-End | 337,941,402.00 | 314,728,533.20 | 28,227,099.01 | 338,528,884.43 | 69,891,218.54 | 1,089,317,137.18 | [Parent Company Statement of Changes in Equity](index=61&type=section&id=8%E3%80%81%E6%AF%8D%E5%85%AC%E5%8F%B8%E6%89%80%E6%9C%89%E8%80%85%E6%9D%83%E7%9B%8A%E5%8F%98%E5%8A%A8%E8%A1%A8) The parent company's total equity increased by 105 million yuan, primarily due to comprehensive income Parent Company Statement of Changes in Equity (Current Period) | Item | Share Capital (Yuan) | Capital Reserve (Yuan) | Surplus Reserve (Yuan) | Retained Earnings (Yuan) | Total Equity (Yuan) | | :--- | :--- | :--- | :--- | :--- | :--- | | I. Balance at Prior Year-End | 337,941,402.00 | 321,973,281.82 | 28,227,099.01 | 222,003,890.85 | 910,145,673.68 | | II. Balance at Beginning of Year | 337,941,402.00 | 321,973,281.82 | 28,227,099.01 | 222,003,890.85 | 910,145,673.68 | | III. Changes this Period | 0 | 0 | 0 | 105,546,822.43 | 105,546,822.43 | | (I) Total Comprehensive Income | 0 | 0 | 0 | 105,546,822.43 | 105,546,822.43 | | IV. Balance at Period-End | 337,941,402.00 | 321,973,281.82 | 28,227,099.01 | 327,550,713.28 | 1,015,692,496.11 | [Company Basic Information](index=64&type=section&id=%E4%B8%89%E3%80%81%E5%85%AC%E5%8F%B8%E5%9F%BA%E6%9C%AC%E6%83%85%E5%86%B5) The company operates in the computer application services industry, focusing on software development, internet services, and gaming - The company was established through a corporate restructuring on November 1, 2010, with an initial share capital of 40 million yuan[156](index=156&type=chunk) - Following an IPO, capitalization of reserves, and asset acquisitions, the registered capital is now **337.94 million yuan**[156](index=156&type=chunk)[157](index=157&type=chunk) - The company's main business includes computer technology and software development, internet information services, "Phone Duipeng" services, online game development, and mobile communication resale[159](index=159&type=chunk) - The company belongs to the computer application services industry[160](index=160&type=chunk) - A total of **6 entities**

贵阳朗玛信息技术股份有限公司 2016 年第一季度报告全文 贵阳朗玛信息技术股份有限公司 2016 年第一季度报告 2016 年 04 月 1 贵阳朗玛信息技术股份有限公司 2016 年第一季度报告全文 第一节 重要提示 本公司董事会、监事会及其董事、监事、高级管理人员保证本报告所载资 料不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准 确性和完整性承担个别及连带责任。 公司负责人王伟、主管会计工作负责人余周军及会计机构负责人(会计主管 人员)马勇声明：保证季度报告中财务报告的真实、完整。 2 除下列董事外，其他董事亲自出席了审议本次季报的董事会会议 未亲自出席董事姓名 未亲自出席董事职务 未亲自出席会议原因 被委托人姓名 靳国文 董事 出差 刘玲 贵阳朗玛信息技术股份有限公司 2016 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否因会计政策变更及会计差错更正等追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期 | | | --- | --- | --- | --- | --- | | | | | 增减 | ...

贵阳朗玛信息技术股份有限公司 2015 年年度报告全文 贵阳朗玛信息技术股份有限公司 2015 年年度报告全文 第一节 重要提示、目录和释义 本公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的 真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和 连带的法律责任。 公司负责人王伟、主管会计工作负责人余周军及会计机构负责人(会计主管 人员)马勇声明：保证年度报告中财务报告的真实、准确、完整。 除下列董事外，其他董事亲自出席了审议本次年报的董事会会议 贵阳朗玛信息技术股份有限公司 2015 年年度报告 2016 年 04 月 1 | 未亲自出席董事姓名 | 未亲自出席董事职务 | 未亲自出席会议原因 | 被委托人姓名 | | --- | --- | --- | --- | | 靳国文 | 董事 | 出差 | 刘玲 | 本报告中如有涉及未来的计划、业绩预测等方面的内容，均不构成本公司 对任何投资者及相关人士的承诺。投资者及相关人士均应对此保持足够的风险 认识，并且应当理解计划、预测与承诺之间的差异。公司在本报告第四节"管理 层分析与讨论"之"九、公司未来发展的展望"部分，详细描述了公司 ...